Yvonne Saenger Gives a Rundown of Immunotherapy Agents for Melanoma
Yvonne Saenger, MD, from Columbia University, gives a rundown of the immunotherapy options for treating melanoma.
Yvonne Saenger, MD, Director of Melanoma Immunotherapy at Columbia University, talks about the immunotherapy agents currently available for melanoma.
Along with ipulimimab, pembrolizimab and nivolumab prolonging survival in patients with melanoma, she discusses the oncolytic virus, a novel therapy using a herpes virus that attacks tumor cells preferentially.
Recent Videos
Related Content
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024Article
This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
